Leukapheresis
Market Overview
The global Leukapheresis Market size is $20.95m in 2019 and is estimated to grow at a CAGR of 7.36% during the forecast period 2020–2025. The market is projected to reach $32.01m by 2025. Leukapheresis is a procedure in which the white blood cells are separated from the blood sample. It is done to reduce the peripheral WBC counts in patients having hematological malignancies. The main application of Leukapheresis procedure is in the treatment of chronic leukemia. It is also used to reduce or alleviate symptoms of hyperleukocytosis and leukostasis, before chemotherapy, and other medical applications.
Key Takeaways
- Leukapheresis market is growing at a CAGR of 7.36% during the forecast period 2020–2025.
- As per The Leukemia & Lymphoma Society (LLS), in 2019, about 61,780 people are expected to be diagnosed with Leukemia. Leukapheresis is a treatment type for leukemia to reduce the count of WBCs. It is also used for other inflammatory diseases such as ulcerative colitis or rheumatoid arthritis.
- North America dominates the market with major share. Leukapheresis disposable segment holds major share by revenue by type.
Type - Segment Analysis
In 2019, the Leukapheresis
disposable segment is said to dominate the market by revenue. This is owing to its
increasing use for cell therapy research applications. They also have regular requirement as compared to leukapheresis devices. These dispocables are also purchased in bulk to meet constant requirements, thus are contributing to the dominance of this segment revenue.
Application - Segment Analysis
The research segment is
said to dominate the Leukapheresis market by application. Growing research in cancer
treatments and cell therapy are said to contribute to the growth of this
segment. This segment is said to be the fastest growing during the forecast
period with a CAGR of 6.3%.
End User - Segment Analysis
The blood component
provider and blood center end use industry is likely to dominate the market
during the base year and is anticipated to do so in the coming years. This is
due to the increasing number of blood donations being done as well as the rising
demand for Leukopaks in conditions such as cancer.
Geography - Segment Analysis
In 2019, the Asia Pacific
region occupied 32% of the global Leukapheresis Market share in terms of
revenue. Increase in government investments and a number of private biotechnology
companies in this region contribute to this dominant share. The rising
geriatric population and increasing investment in research are said to be
responsible for this growth.
Drivers – Leukapheresis Market
·
Growing incidence of diseases such as
leukemia
There are an estimated 399,967 people
living with or in remission from leukemia in the U.S. as per The Leukemia &
Lymphoma Society. The high incidence of leukemia globally is said to drive the Leukapheresis
market.
·
Rising number of blood donations and
surging demand for Leukopaks
As per the WHO statistics, 117.4 million blood donations are collected globally. The rising demand for blood transfusions in patients with leukemia, lymphoma, and other blood disorders is said to contribute to the leukapheresis market growth. Blood donations have a short shelf life so regular supply of blood is required. Leukopaks are blood components procured from blood using leukapheresis. These blood components are required by patients who require such enriched blood cells. This demand for specific blood components will also contribute this market growth.
Challenges – Leukapheresis Market
·
High cost in Leukapheresis procedures
The cost associated with conducting leukapheresis procedure
is very high. The machines used in apheresis are generally very expensive and
this increases the cost of this procedure as well. Along with this, a lack of
skilled professionals trained in this procedure further increases the expense of
this procedure and hence said to restraint the market growth.
Leukapheresis industry outlook
Product Launches, Partnerships, and Business
Expansions are the key strategies of the players in the Leukapheresis Industry.
Leukapheresis top 10 companies include Allcells LLC, Asahi Kasei Medical Co ,
Ltd, Bioivt, Caltag Medsystems Limited, Fresenius Se & Co. Kgaa, Haemonetics
Corporation, Hemacare Corporation, Key Biologics, Llc, Macopharma Sa, Ppa
Research Group, Inc.
Leukapheresis Market Research Scope:
The base year of the study is 2019, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. These provide the key market participants with the necessary business intelligence and help them understand the future of the Leukapheresis market. The assessment includes the forecast, an overview of the competitive structure, the Leukapheresis market share of the competitors, as well as the Leukapheresis market size market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This Leukapheresis market report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include Leukapheresis type, drug type, route of administration, and geographic analysis.
1.1 Definitions and Scope
2. Leukapheresis Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Leukapheresis Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Leukapheresis Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Leukapheresis Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Leukapheresis Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Leukapheresis Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
11.1 Leukapheresis Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Leukapheresis- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Leukapheresis- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Leukapheresis - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Leukapheresis - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Leukapheresis Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Leukapheresis Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Leukapheresis Market - Key Company List by Country Premium
15. Leukapheresis Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Allcells, Llc
15.3 Asahi Kasei Medical Co , Ltd
15.4 Bioivt
15.5 Caltag Medsystems Limited
15.6 Fresenius Se & Co. Kgaa
15.7 Haemonetics Corporation
15.8 Hemacare Corporation
15.9 Key Biologics, Llc
15.10 Macopharma Sa
15.11 Ppa Research Group, Inc
15.12 Precision For Medicine, Inc
15.13 Stemcell Technologies, Inc
15.14 Stemexpress, Llc
15.15 Terumo Bct
15.16 Zenbio, Inc
15.17 Company 16
15.18 Company 17 & More
16.1 Abbreviations
16.2 Sources
17. Leukapheresis Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Leukapheresis Product Market, By Type Market 2023-2030 ($M)1.1 Leukapheresis Device Market 2023-2030 ($M) - Global Industry Research
1.1.1 Apheresis Device Market 2023-2030 ($M)
1.1.2 Leukapheresis Column & Cell Separator Market 2023-2030 ($M)
1.1.3 Leukoreduction Filter Market 2023-2030 ($M)
1.2 Leukapheresis Disposable Market 2023-2030 ($M) - Global Industry Research
2.Global Leukapheresis Product Market, By End User Market 2023-2030 ($M)
2.1 Blood Component Provider And Blood Center Market 2023-2030 ($M) - Global Industry Research
2.2 Academic And Research Institute Market 2023-2030 ($M) - Global Industry Research
2.3 Pharmaceutical And Biotechnology Company Market 2023-2030 ($M) - Global Industry Research
2.4 Hospital And Transfusion Center Market 2023-2030 ($M) - Global Industry Research
3.Global Leukapheresis Product Market, By Type Market 2023-2030 (Volume/Units)
3.1 Leukapheresis Device Market 2023-2030 (Volume/Units) - Global Industry Research
3.1.1 Apheresis Device Market 2023-2030 (Volume/Units)
3.1.2 Leukapheresis Column & Cell Separator Market 2023-2030 (Volume/Units)
3.1.3 Leukoreduction Filter Market 2023-2030 (Volume/Units)
3.2 Leukapheresis Disposable Market 2023-2030 (Volume/Units) - Global Industry Research
4.Global Leukapheresis Product Market, By End User Market 2023-2030 (Volume/Units)
4.1 Blood Component Provider And Blood Center Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Academic And Research Institute Market 2023-2030 (Volume/Units) - Global Industry Research
4.3 Pharmaceutical And Biotechnology Company Market 2023-2030 (Volume/Units) - Global Industry Research
4.4 Hospital And Transfusion Center Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America Leukapheresis Product Market, By Type Market 2023-2030 ($M)
5.1 Leukapheresis Device Market 2023-2030 ($M) - Regional Industry Research
5.1.1 Apheresis Device Market 2023-2030 ($M)
5.1.2 Leukapheresis Column & Cell Separator Market 2023-2030 ($M)
5.1.3 Leukoreduction Filter Market 2023-2030 ($M)
5.2 Leukapheresis Disposable Market 2023-2030 ($M) - Regional Industry Research
6.North America Leukapheresis Product Market, By End User Market 2023-2030 ($M)
6.1 Blood Component Provider And Blood Center Market 2023-2030 ($M) - Regional Industry Research
6.2 Academic And Research Institute Market 2023-2030 ($M) - Regional Industry Research
6.3 Pharmaceutical And Biotechnology Company Market 2023-2030 ($M) - Regional Industry Research
6.4 Hospital And Transfusion Center Market 2023-2030 ($M) - Regional Industry Research
7.South America Leukapheresis Product Market, By Type Market 2023-2030 ($M)
7.1 Leukapheresis Device Market 2023-2030 ($M) - Regional Industry Research
7.1.1 Apheresis Device Market 2023-2030 ($M)
7.1.2 Leukapheresis Column & Cell Separator Market 2023-2030 ($M)
7.1.3 Leukoreduction Filter Market 2023-2030 ($M)
7.2 Leukapheresis Disposable Market 2023-2030 ($M) - Regional Industry Research
8.South America Leukapheresis Product Market, By End User Market 2023-2030 ($M)
8.1 Blood Component Provider And Blood Center Market 2023-2030 ($M) - Regional Industry Research
8.2 Academic And Research Institute Market 2023-2030 ($M) - Regional Industry Research
8.3 Pharmaceutical And Biotechnology Company Market 2023-2030 ($M) - Regional Industry Research
8.4 Hospital And Transfusion Center Market 2023-2030 ($M) - Regional Industry Research
9.Europe Leukapheresis Product Market, By Type Market 2023-2030 ($M)
9.1 Leukapheresis Device Market 2023-2030 ($M) - Regional Industry Research
9.1.1 Apheresis Device Market 2023-2030 ($M)
9.1.2 Leukapheresis Column & Cell Separator Market 2023-2030 ($M)
9.1.3 Leukoreduction Filter Market 2023-2030 ($M)
9.2 Leukapheresis Disposable Market 2023-2030 ($M) - Regional Industry Research
10.Europe Leukapheresis Product Market, By End User Market 2023-2030 ($M)
10.1 Blood Component Provider And Blood Center Market 2023-2030 ($M) - Regional Industry Research
10.2 Academic And Research Institute Market 2023-2030 ($M) - Regional Industry Research
10.3 Pharmaceutical And Biotechnology Company Market 2023-2030 ($M) - Regional Industry Research
10.4 Hospital And Transfusion Center Market 2023-2030 ($M) - Regional Industry Research
11.APAC Leukapheresis Product Market, By Type Market 2023-2030 ($M)
11.1 Leukapheresis Device Market 2023-2030 ($M) - Regional Industry Research
11.1.1 Apheresis Device Market 2023-2030 ($M)
11.1.2 Leukapheresis Column & Cell Separator Market 2023-2030 ($M)
11.1.3 Leukoreduction Filter Market 2023-2030 ($M)
11.2 Leukapheresis Disposable Market 2023-2030 ($M) - Regional Industry Research
12.APAC Leukapheresis Product Market, By End User Market 2023-2030 ($M)
12.1 Blood Component Provider And Blood Center Market 2023-2030 ($M) - Regional Industry Research
12.2 Academic And Research Institute Market 2023-2030 ($M) - Regional Industry Research
12.3 Pharmaceutical And Biotechnology Company Market 2023-2030 ($M) - Regional Industry Research
12.4 Hospital And Transfusion Center Market 2023-2030 ($M) - Regional Industry Research
13.MENA Leukapheresis Product Market, By Type Market 2023-2030 ($M)
13.1 Leukapheresis Device Market 2023-2030 ($M) - Regional Industry Research
13.1.1 Apheresis Device Market 2023-2030 ($M)
13.1.2 Leukapheresis Column & Cell Separator Market 2023-2030 ($M)
13.1.3 Leukoreduction Filter Market 2023-2030 ($M)
13.2 Leukapheresis Disposable Market 2023-2030 ($M) - Regional Industry Research
14.MENA Leukapheresis Product Market, By End User Market 2023-2030 ($M)
14.1 Blood Component Provider And Blood Center Market 2023-2030 ($M) - Regional Industry Research
14.2 Academic And Research Institute Market 2023-2030 ($M) - Regional Industry Research
14.3 Pharmaceutical And Biotechnology Company Market 2023-2030 ($M) - Regional Industry Research
14.4 Hospital And Transfusion Center Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Leukapheresis Market Revenue, 2023-2030 ($M)2.Canada Leukapheresis Market Revenue, 2023-2030 ($M)
3.Mexico Leukapheresis Market Revenue, 2023-2030 ($M)
4.Brazil Leukapheresis Market Revenue, 2023-2030 ($M)
5.Argentina Leukapheresis Market Revenue, 2023-2030 ($M)
6.Peru Leukapheresis Market Revenue, 2023-2030 ($M)
7.Colombia Leukapheresis Market Revenue, 2023-2030 ($M)
8.Chile Leukapheresis Market Revenue, 2023-2030 ($M)
9.Rest of South America Leukapheresis Market Revenue, 2023-2030 ($M)
10.UK Leukapheresis Market Revenue, 2023-2030 ($M)
11.Germany Leukapheresis Market Revenue, 2023-2030 ($M)
12.France Leukapheresis Market Revenue, 2023-2030 ($M)
13.Italy Leukapheresis Market Revenue, 2023-2030 ($M)
14.Spain Leukapheresis Market Revenue, 2023-2030 ($M)
15.Rest of Europe Leukapheresis Market Revenue, 2023-2030 ($M)
16.China Leukapheresis Market Revenue, 2023-2030 ($M)
17.India Leukapheresis Market Revenue, 2023-2030 ($M)
18.Japan Leukapheresis Market Revenue, 2023-2030 ($M)
19.South Korea Leukapheresis Market Revenue, 2023-2030 ($M)
20.South Africa Leukapheresis Market Revenue, 2023-2030 ($M)
21.North America Leukapheresis By Application
22.South America Leukapheresis By Application
23.Europe Leukapheresis By Application
24.APAC Leukapheresis By Application
25.MENA Leukapheresis By Application
26.Asahi Kasei Medical Co , Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Fresenius Se & Co. Kgaa, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Haemonetics Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Hemacare Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Key Biologics, Llc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Terumo Bct, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Allcells, Llc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Stemexpress, Llc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Stemcell Technologies, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Caltag Medsystems Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
36.Zenbio, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
37.Precision For Medicine, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
38.Ppa Research Group, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
39.Bioivt, Sales /Revenue, 2015-2018 ($Mn/$Bn)
40.Macopharma Sa, Sales /Revenue, 2015-2018 ($Mn/$Bn)